Indication · Neurology & Neurosurgery
Peripheral neuropathy and nerve injury
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
115
Cleared or approved since 2000
PMA and De Novo
2
Higher-risk or first-of-kind devices
Breakthrough devices
0
Authorized through June 30, 2026
Recruiting device trials
185
1,288 device trials in all
Devices
113 devices via 510(k). PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- VersaWrap Nerve Protector (VTP-2201)
Alafair Biosciences · 510(k) · Cuff, Nerve · newest 2025 · 3 decisions
59 more devices with a free account
Showing the first 60. Narrow by pathway, or open a device type below.
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
South Valley UniversityAcademic, hospital or other
NCT07070544 · 79 participants · Start Jul 10, 2025 · Primary completion Jan 7, 2026
Device: Electromagnetic Field Therapy: • Frequency: 50 Hz • Intensity: 5-30 mT • Duration: 30 minutes/session • Frequency: 3 sessions/week for 8 weeks Customized Foot Insoles: • Individually tailored based on · For: Diabetes Mellitus; Diabetic Foot Ulcer
Sites: Qina, Egypt
1,287 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- Cuff, Nerve (JXI)30
- Electromyograph, Diagnostic (IKN)27
- Electrode, Needle, Diagnostic Electromyograph (IKT)19
- Device, Galvanic Skin Response Measurement (GZO)18
- Device, Nerve Conduction Velocity Measurement (JXE)10
- Device, Vibration Threshold Measurement (LLN)3
- Evoked Potential Stimulator, Thermal (NTU)3
- Esthesiometer (GXB)1
- Test, Temperature Discrimination (LQW)1
- Optical Neurosurgical Nerve Locator (QWP)1
- In Situ Polymerizing Peripheral Nerve Cap (SBG)1
- In Situ Polymerizing Peripheral Nerve Repair Device (SFD)1
Research
- Device studies on peripheral neuropathy across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.